Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150


Fatal pulmonary thromboembolism after Achilles tendon open repair: A rare case report.

Chun DI, Lee S, Won SH, Cho J.

Medicine (Baltimore). 2017 Nov;96(47):e8887. doi: 10.1097/MD.0000000000008887.


Non-hemorrhage-related adverse effects of rivaroxaban.

Christopoulou EC, Filippatos TD, Elisaf MS.

Arch Med Sci Atheroscler Dis. 2017 Dec 31;2:e108-e112. doi: 10.5114/amsad.2017.72533. eCollection 2017.


Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa.

Siegal D, Lu G, Leeds JM, Karbarz M, Castillo J, Mathur V, Hutchaleelaha A, Sinha U, Kitt M, McClure M, Hollenbach SJ, Curnutte JT, Conley PB, Crowther M.

Blood Adv. 2017 Sep 22;1(21):1827-1838. doi: 10.1182/bloodadvances.2017007112. eCollection 2017 Sep 26.


Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants.

Gao L, Tadrous M, Knowles S, Mamdani M, Paterson JM, Juurlink D, Gomes T.

Healthc Policy. 2017 Nov;13(2):68-78.


Antithrombotic therapy strategies for atrial fibrillation patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis.

Gong X, Tang S, Li J, Zhang X, Tian X, Ma S.

PLoS One. 2017 Oct 12;12(10):e0186449. doi: 10.1371/journal.pone.0186449. eCollection 2017. Review.


Effects of different anticoagulant drugs on the prevention of complications in patients after arthroplasty: A network meta-analysis.

Gao JH, Chu XC, Wang LL, Ning B, Zhao CX.

Medicine (Baltimore). 2017 Oct;96(40):e8059. doi: 10.1097/MD.0000000000008059.


Cardiac tachyarrhythmias and anaesthesia: General principles and focus on atrial fibrillation.

Parida S, Thangaswamy CR.

Indian J Anaesth. 2017 Sep;61(9):712-720. doi: 10.4103/ija.IJA_383_17. Review.


Comparison of postoperative complications after total hip arthroplasty among patients receiving aspirin, enoxaparin, warfarin, and factor Xa inhibitors.

Agaba P, Kildow BJ, Dhotar H, Seyler TM, Bolognesi M.

J Orthop. 2017 Aug 14;14(4):537-543. doi: 10.1016/j.jor.2017.08.002. eCollection 2017 Dec.


Can patients with femoral neck fracture benefit from preoperative thromboprophylaxis?: A prospective randomized controlled trial.

Li Q, Dai B, Xu J, Yao Y, Song K, Zhang H, Chen D, Jiang Q.

Medicine (Baltimore). 2017 Jul;96(29):e7604. doi: 10.1097/MD.0000000000007604.


Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding.

Thalji NK, Camire RM.

Curr Opin Hematol. 2017 Sep;24(5):453-459. doi: 10.1097/MOH.0000000000000369. Review.


Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.

Yhim HY, Lee J, Lee JY, Lee JO, Bang SM.

PLoS One. 2017 May 24;12(5):e0178214. doi: 10.1371/journal.pone.0178214. eCollection 2017.


Direct Oral Anticoagulants Vs. Enoxaparin for Prevention of Venous Thromboembolism Following Orthopedic Surgery: A Dose-Response Meta-analysis.

Boyd RA, DiCarlo L, Mandema JW.

Clin Transl Sci. 2017 Jul;10(4):260-270. doi: 10.1111/cts.12471. Epub 2017 May 23.


Anticoagulation therapy and proximal femoral fracture treatment: An update.

Ktistakis I, Giannoudis V, Giannoudis PV.

EFORT Open Rev. 2017 Mar 13;1(8):310-315. doi: 10.1302/2058-5241.1.160034. eCollection 2016 Aug.


The efficacy and safety of epinephrine for postoperative bleeding in total joint arthroplasty: A PRISMA-compliant meta-analysis.

Teng Y, Ma J, Ma X, Wang Y, Lu B, Guo C.

Medicine (Baltimore). 2017 Apr;96(17):e6763. doi: 10.1097/MD.0000000000006763. Review.


Surgical trial design - learning curve and surgeon volume: Determining whether inferior results are due to the procedure itself, or delivery of the procedure by the surgeon.

Simpson AH, Howie CR, Norrie J.

Bone Joint Res. 2017 Apr;6(4):194-195. doi: 10.1302/2046-3758.64.BJR-2017-0051. No abstract available.


Rivaroxaban Rebound Acute Coronary Event: A Post Marketing Experience.

Agarwal A, Patel A, Mufti O, Jbara Y, Jabbar AA.

Cardiol Res. 2013 Dec;4(6):207-210. doi: 10.4021/cr294w. Epub 2014 Jan 2.


Unmet Needs in Anticoagulant Therapy: Potential Role of Rivaroxaban.

Eikelboom JW, Connolly SJ.

Cardiol Res. 2015 Jun;6(3):267-277. doi: 10.14740/cr413w. Epub 2015 Jun 11. Review.


Use of novel oral anticoagulant agents in venous thromboembolism.

Madan S, Shah S, Dale P, Partovi S, Parikh SA.

Cardiovasc Diagn Ther. 2016 Dec;6(6):570-581. doi: 10.21037/cdt.2016.11.17. Review.


Pharmacokinetics and pharmacodynamics of single doses of rivaroxaban in obese patients prior to and after bariatric surgery.

Kröll D, Stirnimann G, Vogt A, Lai DLL, Borbély YM, Altmeier J, Schädelin S, Candinas D, Alberio L, Nett PC.

Br J Clin Pharmacol. 2017 Jul;83(7):1466-1475. doi: 10.1111/bcp.13243. Epub 2017 Mar 9.


Cost-Effectiveness of Different Strategies for the Prevention of Venous Thromboembolism After Total Hip Replacement in China.

Yan X, Gu X, Xu Z, Lin H, Wu B.

Adv Ther. 2017 Feb;34(2):466-480. doi: 10.1007/s12325-016-0460-0. Epub 2016 Dec 20.

Supplemental Content

Support Center